相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Fibrosis-4 Index vs Nonalcoholic Fatty Liver Disease Fibrosis Score in Identifying Advanced Fibrosis in Subjects With Nonalcoholic Fatty Liver Disease: A Meta-Analysis
Marco Castellana et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)
Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis
Rod S. Taylor et al.
GASTROENTEROLOGY (2020)
Non-invasive tests for liver fibrosis in NAFLD: Creating pathways between primary healthcare and liver clinics
Laurent Castera
LIVER INTERNATIONAL (2020)
Nonalcoholic Fatty Liver Disease: A Challenge from Mechanisms to Therapy
Giovanni Tarantino et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Frequently abnormal serum gamma-glutamyl transferase activity is associated with future development of fatty liver: a retrospective cohort study
Hideki Fujii et al.
BMC GASTROENTEROLOGY (2020)
Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials
Beth A. Davison et al.
JOURNAL OF HEPATOLOGY (2020)
The FIB-8 score: validation of a model to screen patients with non-alcoholic fatty liver disease for significant fibrosis
Pimsiri Sripongpun et al.
JOURNAL OF HEPATOLOGY (2020)
Screening for non-alcoholic fatty liver disease in community setting: A cohort study using controlled attenuation parameter-transient elastography
Nicha Teeratorn et al.
JGH OPEN (2020)
Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis
Jie Li et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)
Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage
Mohammad Shadab Siddiqui et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Non-alcoholic fatty liver disease - A global public health perspective
Zobair M. Younossi
JOURNAL OF HEPATOLOGY (2019)
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
Clinical features and treatment of nonalcoholic fatty liver disease across the Asia Pacific region-the GO ASIA initiative
W-K. Chan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis
Stuart McPherson et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
Diagnostic Accuracy of Noninvasive Fibrosis Scores in a Population of Individuals With a Low Prevalence of Fibrosis
Suzanne E. Mahady et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
Brent A. Neuschwander-Tetri et al.
LANCET (2015)
Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design
Naga P. Chalasani et al.
CONTEMPORARY CLINICAL TRIALS (2009)
The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD
Paul Angulo et al.
HEPATOLOGY (2007)
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection
Richard K. Sterling et al.
HEPATOLOGY (2006)
分享论文
